These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26886283)

  • 1. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.
    Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z
    Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
    Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.
    Fu XY; Zhou WB; Xu J
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1829-1840. PubMed ID: 32141552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.
    Lei L; Wu J; Gu D; Liu H; Wang S
    Tumour Biol; 2016 Aug; 37(8):11073-9. PubMed ID: 26906552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
    Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
    Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of fascin-1 expression suppresses cell migration and invasion of non-small cell lung cancer by regulating the MAPK pathway.
    Zhao D; Zhang T; Hou XM; Ling XL
    Biochem Biophys Res Commun; 2018 Mar; 497(2):694-699. PubMed ID: 29458026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.
    Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E
    Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP promotes erlotinib resistance in human non-small cell lung cancer cells.
    Hsu PC; You B; Yang YL; Zhang WQ; Wang YC; Xu Z; Dai Y; Liu S; Yang CT; Li H; Hu B; Jablons DM; You L
    Oncotarget; 2016 Aug; 7(32):51922-51933. PubMed ID: 27409162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
    Zhang Y; Yang X; Wu H; Zhou W; Liu Z
    Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting YAP in malignant pleural mesothelioma.
    Zhang WQ; Dai YY; Hsu PC; Wang H; Cheng L; Yang YL; Wang YC; Xu ZD; Liu S; Chan G; Hu B; Li H; Jablons DM; You L
    J Cell Mol Med; 2017 Nov; 21(11):2663-2676. PubMed ID: 28470935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
    Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
    Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
    Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
    Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
    Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer.
    Lo Sardo F; Forcato M; Sacconi A; Capaci V; Zanconato F; Di Agostino S; Del Sal G; Pandolfi PP; Strano S; Bicciato S; Blandino G
    Carcinogenesis; 2017 Jan; 38(1):64-75. PubMed ID: 27797825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.